Sartorius AG (SRT3d)
FRA • Healthcare
September 10, 2026 at 14:40 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every €100 in revenue, Sartorius AG keeps €5 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Sartorius AG trailed consensus on both the top and bottom line in the second fiscal quarter of 2026, reported July 23, as adjusted EPS of EUR 1.29 trailed the EUR 1.31 estimate (-1.5%) and revenue of EUR 911.8 million trailed the EUR 934.2 million estimate (-2.4%). Revenue rose ~3% to roughly EUR 911.8 million, up from about EUR 884.3 million a year ago, while gross margin stood near 48% and operating margin was around 20%, with operating income of roughly EUR 177.9 million. Net income increased about 27% to around EUR 41.2 million versus roughly EUR 32.5 million a year ago. The quarter generated operating cash flow of about EUR 175.5 million. For the next period, consensus calls for EPS of EUR 1.24 on revenue of EUR 892.8 million.
About Sartorius AG
Sartorius AG trades on XETRA as SRT3.DE and makes laboratory and bioprocess tools for healthcare and life sciences customers. Its portfolio spans instruments, consumables, and related services used from research through manufacturing and quality testing, and it recorded EUR 3.5 billion of revenue in FY2025.
Today's Snapshot
SRT3d closed 1.4% lower at 233.60, while its sector was flat. Volume was about a quarter of its usual level.
Trading Volume
Below 10d avg (65.6K)
16.4K
vs S&P 500 Today
Underperforming Market
-0.88%
Updated: September 10, 2026 at 14:02 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$231.85 - $239.57Sell
- RSI (14)43.99Neutral
- Stochastic %K (14, 3, 3)22.66Neutral
- MACD Level (12, 26)0.70Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.